Uscom Limited · ASX:UCM
Uscom — Shareholder Meeting (2015)
42 slides from Uscom's shareholder meeting presentation, 2015
Slide 1: Uscom Limited 2015 Annual General Meeting
Uscom Limited 2015 ANNUAL GENERAL MEETING
Slide 2: Board of Directors
Board of Directors: Prof Rob Phillips (Executive) Ms Sheena Jack (Non-executive) Mr Christian Bernecker (Non-executive) Company Secretary – Ms Catherine Officer BDO Auditors – Mr Tim Sydenham Uscom Annual General Meeting 2015
Slide 3: Meeting agenda
Quorum / Open meeting Chairman’s Welcome, Introduction of Board Members Chairman’s Presentation GM Operations Update US Operations Update Objectives 2016 Notice of Meeting – Taken as Read Consideration of Reports Business – Resolutions 1 - 7 Close of Meeting Question and Answer
Slide 4: Associate Professor Rob Phillips
Associate Professor Rob Phillips PhD(Med), MPhil(Med), FASE, DMU(Cardiol) Executive Chairman, Chief Executive Officer, Head Clinical Science Uscom Annual General Meeting 2015
Slide 5: It is simple to start a business, but it takes time to build
“It is simple to start a business, but it takes time to build a global medical technology Company…… Now is Uscom’s time.” Uscom Annual General Meeting 2015
Slide 6: Distribution. Sales. Revenue.
Distribution. Sales. Revenue. Uscom Annual General Meeting 2015
Slide 7: Revenue +48%, sales +59%
Revenue +48%, sales +59% Record growth and sales of USCOM 1A devices Distribution increased 57% Acquisition of 100% of Thor Laboratories Raised capital ($2.1m) and paid cash for acquisition Johnson&Johnson Innovation AusBiotech Company of the Year Established UK entity – Uscom Medical
Slide 8: Distribution, sales and revenue growth
Distribution Agreements Revenue and Income 40 $2,500,000 36 35 $2,039,426 $2,000,000 30 25 23 $1,500,000 $1,377,716 20 $1,010,942 15 $1,000,000 12 10 +48% +57% $500,000 +36% +48% 5 0 $0 2013 2014 2015 2013 2014 2015 Current revenue only from USCOM 1A Revenue lag from distributor appointments - reven
Slide 9: Uscom has acquired 100% of Thor Laboratories - Asthma
Uscom has acquired 100% of Thor Laboratories - Asthma * Company Overview Uscom benefits High fidelity digital ultrasonic spirometers Cash flow positive, revenue of $500k Established manufacturing - 15 years Accredited international manufacturing Global reach 4 + 3 products, CE, FDA, TGA
Slide 10: Product Release – 7 new products
Product Release – 7 new products Uscom high fidelity, multi-path digital ultrasonic spirometers Series Name: Spirosonic™ Logo: Product Features: Multi-path ultrasonic sensors Auto calibration Research quality Software guided examination and report FreeFlo tube - low resistance, no turbines
Slide 11: Flo, Mobile, Smart spirometers
1. Flo 2. Mobile 3. Smart High fidelity, multi-path digital ultrasonic spirometers Uscom Annual General Meeting 2015
Slide 12: HD, Pro, SpiroReader, SpiroReporter
4. HD 5. Pro 6. SpiroReader 7. SpiroReporter Uscom Annual General Meeting 2015
Slide 13: SmartSpacer, WiFi, Whistler
8. SmartSpacer 9. WiFi 10. Whistler Dose management Home care Neonatal asthma diagnostic Uscom Annual General Meeting 2015
Slide 14: Uscom Annual General Meeting 2015
Uscom Annual General Meeting 2015
Slide 15: Oxygen delivery from nose to toes
“Oxygen delivery from nose to toes” * Fluid, Sepsis Hypertension & COPD & Heart Failure Vascular Health & Asthma CE, FDA, TGA, CFDA CE, FDA, TGA, CFDA (active) CE, FDA, TGA US 1.3bn market * US 1.7bn market * US 4b+700m market ** CAGR of 7.6% * CAGR of 11.5% * CAGR of 6.5% * USCOM
Slide 16: Why the Uscom mission is important for medicine
Why the Uscom mission is important for medicine * Life is dependent on the delivery of adequate oxygen Deprived of oxygen the cells begin to die in 2 minutes The circulation delivers oxygen to the cells Air, carrying oxygen, is inhaled into the lungs Oxygen is transferred to the blood in the
Slide 17: Patents - Real IP, real value
Uscom BP+ Thor Granted 12 21 3 Pending 4 1 1 Patents - Real IP, real value Uscom Annual General Meeting 2015
Slide 18: Over 800 USCOM units sold worldwide
Over 800 USCOM units sold worldwide • • •• • • ••• •••• ••• ••• • •• • •• • • • • • • • • •• • •• Key Markets 1. Nth America – 8% 2. Europe – 27% 3. AsiaPAC – 65% Uscom Annual General Meeting 2015
Slide 19: Global distributors
Nick Schicht Steve Haken Andrew Kenig Denise Pater Tina Wu Rik Denicke Rob Phillips Global Euro Aus Global Global USA Global Bev Jacobson Richard Scott Hanna Maartensson George Tang Lindy Belleza George Ferenczi Hagay Gilad Steve Wilson Global Global Aus Aus Aus Global Aus USA Uscom Annual General M
Slide 20: Thor Budapest team
1. George Ferenczi Thor and product 12. Balazs Herczeg Mechanical engineer, development product dev 2. Nikolett Makovinski General Manager 13. Szabolcs Reichhardt Quality Assurance 3. Nora Sima Marketing Manager 14. George Szabo Software developer 4. Zoltan Rozsnyik Software developer 15. Szabolcs H
Slide 21: Paediatric intensive care in Hungary; Saving Children with Sepsis
“Paediatric intensive care in Hungary; Saving Children with Sepsis Uscom Annual General Meeting 2015 https://www.youtube.com/watch?v=zvFXUnKiAH8
Slide 22: Published papers on USCOM
“USCOM for screening in pregnancy” “USCOM to replace catheters in children” 2015 410 46 + papers papers 1. Tiralongo GM, Presti DL, Pisani I, Gagliardi G, Scala RL, Novelli GP, Vasapollo B, Andreoli A, Valensise H. Assessment of total vascular resistance and total body water in normotensive women du
Slide 23: Awards: AusBiotech Company of the Year
Uscom AusBiotech Company of the Year Johnson & Johnson Innovation Industry Excellence Awards Uscom Annual General Meeting 2015
Slide 24: Mr Nick Schicht
Mr Nick Schicht Uscom General Manager Uscom Annual General Meeting 2015
Slide 25: Regions where Uscom products are cleared for sale
Uscom products are cleared for sale in the following regions Australia - TGA USA - FDA 510k Europe - CE China - CFDA Canada - Canada Health CE is also used for other countries as a basis for registration Uscom Annual General Meeting 2015
Slide 26: Regulatory Audits and Renewal
Regulatory Audits and Renewal Uscom is audited quarterly, yearly and by schedule by various governing bodies Current update activities include BP+ improvements and FDA SpiroSonic product addition Uscom Annual General Meeting 2015
Slide 27: Manufacturing
Manufacturing Uscom products are manufactured USCOM 1A and BP+ in Sydney, Australia Thor range in Hungary Activities have begun to Manufacture BP+ in Hungary Manufacture SpiroSonic in Hungary Uscom Annual General Meeting 2015
Slide 28: Mr Stephen Wilson
Mr Stephen Wilson Uscom Vice President US Business Development Uscom Annual General Meeting 2015
Slide 29: Uscom Annual General Meeting 2015
Uscom Annual General Meeting 2015
Slide 30: Care
Care Uscom Annual General Meeting 2015
Slide 31: US strategy: Uscom 1A, BP+, SpiroSonic
Uscom 1A BP + SpiroSonic OEM + Establish CPT Code + Leverage CPT Code + Clinical Grade 510K + Connected Spiro + Target High Acuity + Establish FDA 510K + Position Portfolio + Partner into Home Distributors and Distribution with a disposable Health Uscom Annual General Meeting 2015
Slide 32: Product reimbursement codes and prices
Product Measure Region Code Price (AUD) Status Uscom BP+ Central BP USA 93050 $25.60 S* USCOM 1A Cardiac Output USA 76999 $107.00 S** Cardiac Output China 310701023 $44.00 ✓ Cardiac Output China 220600010 $13.50 ✓ + $2.50 measure Cardiac Output Australia TBD TBD S** Uscom Thor Spirometry USA 94010 $
Slide 33: Original equipment manufacturer (OEM) definition
Original equipment manufacturer (OEM) is a term used when one company makes a part or subsystem that is used in another company's end product Uscom Annual General Meeting 2015
Slide 34: Three product ranges entering profit phase
Three product ranges entering profit phase Global Profit Concept Product Pilot Validation Regulatory Revenue Distribution 2016 USCOM ✓ ✓ ✓ ✓ ✓ ✓ ✓ ±✓ Uscom BP+ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ±✓ Thor ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ Investment to Profit IP shifting to profit Uscom Annual General Meeting 2015
Slide 35: $20m revenue by 2020
Thor Total Revenue 20,000,000 18,000,000 16,000,000 BP+ 14,000,000 12,000,000 Thor $ 10,000,000 BP+ USCOM 8,000,000 6,000,000 USCOM 4,000,000 2,000,000 0 2015 2016* 2017* 2018* 2019* 2020* $20m revenue by 2020 - 5 year CAGR of 58% Uscom Annual General Meeting 2015
Slide 36: Uscom Share Price
Uscom Share Price 25 22 21 20 15 15 10.5 10 6.7 5 0 Jan-12 2012 vwap 2013 vwap 2014 vwap 2015 vwap 5,166,718 shares traded $1,066,182 by value Uscom Annual General Meeting 2015 VWAP 20.6c
Slide 37: 12 month projections and price and cap value targets
5th Oct 2015 5th Oct 2016 12mth Change 0.14c (14m) 0.42c (42m) +200% 12 month Projections and price and cap value targets Ben Kakoschke – 5th October, 2015 Uscom Annual General Meeting 2015
Slide 38: Risks and Mitigants
Risks Mitigants Global markets unpredictable Diversified and expanded products Thor integration & key staff retention Earn outs in Thor deal structure Ongoing Thor business management Earn outs in Thor deal structure Competitiveness of market sectors Senior sales and marketing person
Slide 39: Milestones 2016
Milestones 2016 More products - Global launch BP+ Global launch SpiroSonic products (+8) More Revenue - Continue sales growth ±50% More and better distribution Cross distribute Thor/USCOM/BP+ US market development Reimbursement drive Global operations – Grow US, UK and Budapest Grow China Market val
Slide 40: 2016 Strategy
2016 Strategy Product. Distribution. Sales. Revenue. Uscom Annual General Meeting 2015
Slide 41: It is simple to start a business, but it takes time to build
“It is simple to start a business, but it takes time to build a global medical technology Company…… Now is Uscom’s time.” Uscom Annual General Meeting 2015
Slide 42: Questions and Discussion
Uscom Limited 2015 Annual General Meeting Questions and Discussion The Measure of Life